Robotics & Machine Learning Daily News2024,Issue(Feb.14) :66-67.

U.S. Food and Drug Administration (FDA) Reports Findings in Artificial Intelligence (Decision region analysis for generalizability of artificial intelligence models: estimating model generalizability in the case of cross-reactivity and ...)

Robotics & Machine Learning Daily News2024,Issue(Feb.14) :66-67.

U.S. Food and Drug Administration (FDA) Reports Findings in Artificial Intelligence (Decision region analysis for generalizability of artificial intelligence models: estimating model generalizability in the case of cross-reactivity and ...)

扫码查看

Abstract

New research on Artificial Intelligence is the subject of a report. According to news reporting originating from Silver Spring, Maryland, by NewsRx correspondents, research stated, “Understanding an artificial intelligence (AI) model’s ability to generalize to its target population is critical to ensuring the safe and effective usage of AI in medical devices. A traditional generalizability assessment relies on the availability of large, diverse datasets, which are difficult to obtain in many medical imaging applications.”

Key words

Silver Spring/Maryland/United States/North and Central America/Artificial Intelligence/Emerging Technologies/Machine Learning/U.S. Food and Drug Administration

引用本文复制引用

出版年

2024
Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
段落导航相关论文